Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy

Thomas H Beckham¹, Brandon S Imber¹, Charles B Simone 2nd^{1

2}

Affiliations

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² New York Proton Center, New York, NY, USA.

Editorial

Thomas H Beckham et al. Ann Transl Med. 2019 Jul.

. 2019 Jul;7(Suppl 3):S98.

doi: 10.21037/atm.2019.04.58.

Thomas H Beckham¹, Brandon S Imber¹, Charles B Simone 2nd^{1

2}

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² New York Proton Center, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
Franzese C, Franceschini D, Di Brina L, DʼAgostino GR, Navarria P, Comito T, Mancosu P, Tomatis S, Scorsetti M. Franzese C, et al. J Urol. 2019 Jan;201(1):70-75. doi: 10.1016/j.juro.2018.08.049. J Urol. 2019. PMID: 30577391

1. Franzese C, Franceschini D, Di Brina L, et al. Role of stereotactic body radiation therapy for the management of oligometastatic renal cell carcinoma. J Urol 2019;201:70-6. 10.1016/j.juro.2018.08.049 - DOI - PubMed
1. Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 1996;34:251-66. 10.1016/0360-3016(95)02029-2 - DOI - PubMed
1. Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol 2010;21:1839-45. 10.1093/annonc/mdq028 - DOI - PubMed
1. Molitoris JK, Diwanji T, Snider JW, III, et al. Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy. Transl Lung Cancer Res 2019;8:24-31. 10.21037/tlcr.2018.09.25 - DOI - PMC - PubMed
1. Baumann BC, Nagda SN, Kolker JD, et al. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol 2016;114:65-9. 10.1002/jso.24268 - DOI - PubMed